Vera Donadono

Dr. Vera Donadono

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 March 2015 in The Journal of Maternal-Fetal & Neonatal Medicine
Verified
Journal Article
Closed access
GSGabriele Saccone
Gabriele Saccone
LSLaura Sarno
Laura Sarno
ARAmanda Roman
Amanda Roman
VDVera Donadono
Vera Donadono
GMGiuseppe Maria Maruotti
Giuseppe Maria Maruotti
PMPasquale Martinelli
Pasquale Martinelli
To evaluate the efficacy of 5-methyl-tetrahydrofolate (5-MTHF) supplementation in prevention of recurrent preeclampsia. Retrospective cohort of women who received daily oral 5-MTHF 15 mg supplementation as prophylactic treatment since first trimester for recurrent preeclampsia were compared with women who did not. All asymptomatic singleton gestations with prior preeclampsia (in the previous pregnancy) were included. Women with chronic hypertension were excluded. The primary outcome was the incidence of preeclampsia. Three hundred and three singleton gestation met the inclusion criteria: 157 received 5-MTHF, while 146 did not (control group). Women who received 5-MTHF had a significantly lower incidence of recurrent overall preeclampsia (21.7% versus 39.7%; odds ratio (OR) 0.57, 95% confidence interval (CI) 0.25, 0.69), severe preeclampsia (3.2% versus 8.9%; OR 0.44, 95% CI 0.12-0.97) and early-onset preeclampsia (1.9% versus 7.5%; OR 0.34, 95% CI 0.07-0.87) compared to control. The intervention group delivered about 10 d after the control and had higher birth weight. This retrospective study showed that women with prior preeclampsia who received daily oral 5-MTHF 15 mg supplementation had a significantly lower incidence of overall preeclampsia, severe preeclampsia and early-onset preeclampsia. Randomized controlled trials are needed to confirm our findings.

25 February 2025 in Ultrasound in Obstetrics & Gynecology
Verified
Journal Article
Open access
VDVera Donadono
Vera Donadono
PKP. Koutikwar
P. Koutikwar
ABA. Banerjee
A. Banerjee
MIM. Ivan
M. Ivan
CCC. S. Colley
C. S. Colley
RNRaffaele Napolitano
Raffaele Napolitano
Objective: To compare pregnancy outcome in women at high risk of preterm birth undergoing the modified Wurm (two monofilament sutures) vs those undergoing the McDonald (single braided suture) transvaginal cervical cerclage technique. Methods: This was a single‐center prospective observational study of all women with a singleton pregnancy attending a prematurity surveillance clinic because of an increased risk of preterm birth, and undergoing history‐ or ultrasound‐indicated transvaginal cervical cerclage. Two cerclage techniques were evaluated and the choice of cerclage was at the physician's discretion. In the modified Wurm technique using monofilament material, two circumferential sutures are placed with two insertions each (four in total). Outcomes were compared vs those of women undergoing the McDonald technique (single braided suture using a diamond‐type insertion method with four insertions in total). Primary outcome was the rate of preterm birth at < 32 weeks' gestation, with planned subanalyses according to cervical cerclage indication (history‐ or ultrasound‐indicated), preterm birth rate at any gestational age (< 37, < 34, < 28 and < 24 weeks), and sonographic cervical length (CL) of ≤ 25 mm and ≤ 15 mm. Secondary outcome measures included maternal and neonatal adverse events and outcomes, including the pre‐ and postsurgical characteristics. In addition, a reproducibility analysis using Bland–Altman plots was performed to evaluate the intra‐ and interobserver reproducibility in assessment of CL on ultrasound examination before and after cerclage. Results: In total, 147 patients were included in the final analysis: 55 (37%) received modified Wurm cerclage and 92 (63%) received McDonald cerclage. Other than race, demographic characteristics were comparable between the two groups. Of these, 22 (40%) women in the modified Wurm group had history‐indicated cerclage, vs 50 (54%) women in the McDonald group; the remaining cerclages were ultrasound‐indicated. In women with a short CL (≤ 25 mm), there was a significantly lower rate of preterm birth at < 32 weeks' gestation after modified Wurm compared with the McDonald technique (3 (9%) vs 14 (29%); adjusted odds ratio (aOR), 0.25 (95% CI, 0.06–0.95); P = 0.042). However, the study was underpowered to provide definitive conclusions. In the overall population, there was no significant difference in preterm birth rate for < 32 weeks' gestation between the two techniques (7 (13%) vs 22 (24%); aOR, 0.51 (95% CI, 0.20–1.33); P = 0.169). There was no difference in overall surgical complications between the two techniques. The pregnancy loss rate and composite neonatal morbidity/mortality rate were comparable between the two groups (2 (4%) vs 7 (8%); odds ratio (OR), 0.47 (95% CI, 0.09–2.33); P = 0.485; and 5 (9%) vs 11 (13%); OR, 0.68; (95% CI, 0.22–2.09); P = 0.593, respectively). Conclusions: In high‐risk women with a sonographic short CL, placement of a modified Wurm cervical cerclage is associated with a lower rate of preterm birth < 32 weeks compared with McDonald cervical cerclage. Further research in larger cohorts is needed to confirm this finding and to determine if this technique reduces the preterm birth rate after elective cervical cerclage without CL shortening. © 2025 The Author(s). Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.

21 May 2021 in Diagnostics
Verified
Journal Article
Open access
PDF file
VDVera Donadono
Vera Donadono
ACAngelo Cavallaro
Angelo Cavallaro
NRNia Roberts
Nia Roberts
CIChristos Ioannou
Christos Ioannou
APAris T. Papageorghiou
Aris T. Papageorghiou
RNRaffaele Napolitano
Raffaele Napolitano
Ultrasound-based assessment of the fetal nervous system is routinely recommended at the time of the mid-trimester anatomy scan or at different gestations based on clinical indications. This review evaluates the methodological quality of studies aimed at creating charts for fetal brain structures obtained by ultrasound, as poor methodology could explain substantial variability in percentiles reported. Electronic databases (MEDLINE, EMBASE, Cochrane Library, and Web of Science) were searched from January 1970 to January 2021 to select studies on singleton fetuses, where the main aim was to construct charts on one or more clinically relevant structures obtained in the axial plane: parieto-occipital fissure, Sylvian fissure, anterior ventricle, posterior ventricle, transcerebellar diameter, and cisterna magna. Studies were scored against 29 predefined methodological quality criteria to identify the risk of bias. In total, 42 studies met the inclusion criteria, providing data for 45,626 fetuses. Substantial heterogeneity was identified in the methodological quality of included studies, and this may explain the high variability in centiles reported. In 80% of the studies, a high risk of bias was found in more than 50% of the domains scored. In conclusion, charts to be used in clinical practice and research should have an optimal study design in order to minimise the risk of bias and to allow comparison between different studies. We propose to use charts from studies with the highest methodological quality.

18 March 2022 in Journal of Ultrasound in Medicine
Verified
Journal Article
Closed access
VDVera Donadono
Vera Donadono
GGGaëlle Ambroise Grandjean
Gaëlle Ambroise Grandjean
MSMarie‐Louise Stegen
Marie‐Louise Stegen
ACAdeline Collin
Adeline Collin
CBCharline Bertholdt
Charline Bertholdt
RNRaffaele Napolitano
Raffaele Napolitano

30 August 2021 in European Journal of Clinical Microbiology & Infectious Diseases
Verified
Journal Article
Closed access
PDF file
VDVera Donadono
Vera Donadono
GSGabriele Saccone
Gabriele Saccone
LSLaura Sarno
Laura Sarno
GEGiuseppina Esposito
Giuseppina Esposito
LMLaura L. Mazzarelli
Laura L. Mazzarelli
GMGiuseppe M. Maruotti
Giuseppe M. Maruotti

24 April 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
VDVera Donadono
Vera Donadono
NMNicky Manning
Nicky Manning
LILawrence Impey
Lawrence Impey
Despite its many clinical applications, indomethacin is seldom used in pregnancy, principally because of concerns regarding the potential for constriction of the arterial duct. The aim of this study was to document adverse antenatal effects and postnatal outcomes after in utero exposure to low-dose indomethacin. We studied a retrospective cohort of pregnancies between 2005 and 2016 at the John Radcliffe Hospital, Oxford, UK, in which mothers at extremely high risk of preterm birth were treated as prophylaxis with indomethacin 25 mg, 12 hourly, before 29 weeks. Antenatal effects on the arterial duct and postnatal outcomes were analysed. Overall, 198 fetuses had in utero follow-up, and 13 (6.6%) had ductal constriction, all within 9 days of starting treatment. No ductal constriction was seen in pregnancies when therapy was started before 20 weeks, and all effects were reversed after cessation of therapy. An analysis of postnatal complications was possible in 181 neonates. There were eight (4.4%) neonatal deaths, all but one associated with extreme preterm birth. Seven (5%) patent ductus arteriosus cases occurred in the 140 neonates delivered after 28 weeks who were alive at discharge. Postnatal complications were not more common in neonates in whom antenatal ductal constriction had been demonstrated. In conclusion, fetuses exposed to prolonged low dose indomethacin have a low incidence of in utero complications; these complications can be diagnosed with ultrasound and are reversible. Adverse postnatal events are related to gestation at birth and do not appear more common.